Benzinga | May 10, 2021 07:10AM EDT

Diffusion Pharmaceuticals Q1 EPS $(0.06) Misses $(0.04) Estimate

Diffusion Pharmaceuticals (NASDAQ:DFFN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.04) by 50 percent. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year.